Increased incidence of melanoma in Utah points to overdiagnosis
A letter published today by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the
New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
Melanoma death rates have been decreasing in recent years both in Utah and the United States, a trend likely attributable to new, more effective treatments, like immunotherapy. However, melanoma remains the deadliest type of skin cancer, and the incidence of melanoma diagnoses in Utahns is higher than in any other state.
Sequential administration of immunotherapy and targeted therapy prolongs anti-tumor responses news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
E-Mail
TAMPA, Fla. - Advanced melanoma is one of the deadliest types of cancer, with a 5-year survival rate of only 27% for patients with distant metastases. Recent advances in targeted therapies and immunotherapies have greatly improved patient prognosis; however, many patients eventually develop resistance and disease recurrence. Researchers at Moffitt Cancer Center are investigating how to combine and sequence new therapies to improve survival. In a new article published in
Cancer Immunology Research, the Moffitt team shows that sequential administration of immunotherapy followed by targeted therapy prolongs anti-tumor responses in preclinical models and may be a potential treatment option for patients.
The Skin Cancer Treatment Center Advocates for Sunscreens in Sun Protection menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Through the fourth quarter of 2020, businesses in Aiken received $15.1 million in health-related relief from the CARES act issued by the Department of Health and Human Services.
According to numbers reported through the fourth quarter of 2020, businesses in South Carolina received $1.2 billion in health-related relief from the CARES act issued by the Department of Health and Human Services. The largest recipient of funding in the state was Prisma Health-Upstate with a total of $131 million. The average loan size in the city was $145,137 while the state s average loan amount was $258,718.
Of the money distributed, $30 billion went out automatically to health providers based on previous year medicare payments. If the money wasn t returned within 90 days the provider is then automatically entered into the repayment terms that are issued by HHS. With the money going out automatically and the rules constantly changing, some of the businesses that received the money weren t eligible to r